Labiotech.eu

News and Trends 8 Dec 2016

Meet the Newest ALS Pioneer Company from Switzerland

AL-S Pharma was just born with the only purpose of developing a drug candidate for ALS, a rare condition for which no effective treatments exist. The parents of the newborn company are Neurimmune, a biotech from Zurich that uses high throughput technology to develop treatments for neurodegenerative diseases like Alzheimer’s and Parkinson’s, and TVM Capital Life Science. […]

December 8, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 8 Dec 2016

The Munich Biotech Mafia expand to the US with a New TCR Startup

TCR2 Therapeutics was backed by the Munich biotech mafia, a group of wealthy veteran biotech leaders that seem to be taking over the promising immuno-oncology field. TCR2 Therapeutics has kicked off with a €41.2M ($44.5M) Series A round led by MPM Capital in the US and F2 Ventures in London. The new company, based in Boston, […]

December 8, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 8 Dec 2016

UPDATE: No Clear Winner in the CRISPR Patent Battle

Today marks an inflection point in the future of medicine: both parties fighting for the ownership of CRISPR have made their oral arguments in front of a jury. Who will win the rights to exploit a technology that could be used to cure any genetic disease? CRISPR has been hailed as the ‘scientific discovery of the […]

December 8, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

Screenshot 2016 12 07 at 4.24.41 PM e1481190128909

News and Trends 8 Dec 2016

Video: How is European Biotech changing the World?

We had the amazing opportunity to hear an overview of biotech in Europe at Labiotech Refresh from Philippe Pouletty, co-founder and managing director of Truffle Capital. Philippe has an incredibly extensive experience in biotech as a founder of multiple companies and VCs. He witnessed how biotech got big over the years with the first innovations coming […]

December 8, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 7 Dec 2016

Investors bid on Nordic Nanovector’s Hottest Cancer Antibodies

Nordic Nanovector has bagged €55M to push its pipeline forward through the clinic. Investors seem to be attracted by its ARC and ADC programs, using some of the hottest antibody technologies to treat cancer. Nordic Nanovector develops antibody-radionuclide conjugates (ARCs) to treat non-Hodgkin lymphoma (NHL) and recently entered the trending antibody-drug conjugate (ADC) field to fight against leukemia. These […]

December 7, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 7 Dec 2016

Ask the Biotech Recruiter: Here are 7 Signs it’s Time to Talk to the Headhunters

Finding a new executive is never easy. Is it time to ask for help? The biotech headhunters at Pact & Partners can lend a hand! How long have you been looking to fill a top-level position at your company? Is it taking more time than expected, and are you stuck scratching your head? Are you […]

December 7, 2016 - 6 minutesmins - By External Contributor

News and Trends 7 Dec 2016

UPDATE: More Good News on a Cannabis Derivative for Epilepsy

Update (07/12/2017): GW Pharma has announced more positive Phase III results for Epidiolex, pushing the drug closer to the market and a win for supporters of legalizing marijuana. Originally published on 27/09/2016 GW Pharmaceuticals just released the results of its third successful Phase III clinical trial for Epidiolex (cannabidiol), a drug that can reduce the frequency of […]

December 7, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 6 Dec 2016

Sanofi Jumps into the Biosimilars Market aiming for Asia

Sanofi is joining the biosimilars trend to challenge Roche’s best-selling biological with a partnership that aims to take over the Chinese cancer market. Sanofi is going after the €6.8B ($7.3B) that Roche’s Rituxan/MabThera (rituximab), the second top-selling biological, made last year in revenues. The French pharma has signed a deal worth up to €219M ($236M) […]

December 6, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 6 Dec 2016

How is European Immuno-Oncology fighting Blood Cancer?

From leukemia to multiple myeloma, biotech is working hard to cure blood cancer. This year’s edition of the American Society of Hematology (ASH) annual meeting features immuno-oncology therapies developed by the best European biotechs, with Novartis taking the lead in the CAR-T field. The 58th ASH annual meeting is wrapping up today, after the best companies […]

December 6, 2016 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 5 Dec 2016

Another Pharma sloughs off Small Molecules to focus on Biologics

BI has taken an axe to its small molecule discovery program in order to focus on immuno-oncology in the latest farewell to old-school chemical drugs. Over 90% of the drugs on the market today are small molecules, but the bell has been tolling for these therapies for some time now as biopharma is increasingly focused […]

December 5, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 5 Dec 2016

Video: Chatting with Immunocore about the Potential of Immuno-oncology

At Refresh in Paris, I had the opportunity to ask Eva-Lotta Allan,CBO of one of Europe’s hottest companies, Immunocore, some pointed questions. Immunocore is famous as one of the biggest biotech successes in Europe: the company raised the largest round ever on the continent (€300M!), built a solid technological platform and recruited top talents to manage […]

December 5, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 5 Dec 2016

Rethinking Bioplastics: Future Directions in the Industry

Where are bioplastics going? Last week, 300 experts came together in Berlin to “rethink Bioplastics” and their role in the much-hailed circular economy. The diversity of speakers and exhibitors at the 11th edition of the European Bioplastics Conference offers, in itself, an overview of the different fields and players that make up the bioplastics industry. […]

December 5, 2016 - 6 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Meet the Newest ALS Pioneer Company from Switzerland

The Munich Biotech Mafia expand to the US with a New TCR Startup

UPDATE: No Clear Winner in the CRISPR Patent Battle

Video: How is European Biotech changing the World?

Investors bid on Nordic Nanovector’s Hottest Cancer Antibodies

Ask the Biotech Recruiter: Here are 7 Signs it’s Time to Talk to the Headhunters

UPDATE: More Good News on a Cannabis Derivative for Epilepsy

Sanofi Jumps into the Biosimilars Market aiming for Asia

How is European Immuno-Oncology fighting Blood Cancer?

Another Pharma sloughs off Small Molecules to focus on Biologics

Video: Chatting with Immunocore about the Potential of Immuno-oncology

Rethinking Bioplastics: Future Directions in the Industry

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!